3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Plasma cell
1
Lymphoid
1
Genitourinary
1
Dermatologic
1
Breast
1
Conditions
Sarcoma
1
Multiple Myeloma
1
Melanoma
1
Lymphoma
1
Kidney Neoplasms
1
Breast Neoplasms
1
Interventions
pembrolizumab
9
Cyclophosphamide
6
fludarabine phosphate
4
aldesleukin
3
Radiotherapy
3
Gemcitabine
3
Drug Therapy
3
Docetaxel
3
Cetuximab
3
temsirolimus
2
sargramostim
2
motexafin gadolinium
2
liposomal doxorubicin
2
fludarabine
2
entinostat
2
durvalumab
2
belinostat
2
atezolizumab
2
Sirolimus
2
Paclitaxel
2
Methods
2
Metformin
2
Irinotecan
2
Interferon-alpha
2
Bortezomib
2
3-(8-amino-1-(2-phenylquinolin-7-yl)imidazo(1,5-a)pyrazin-3-yl)-1-methylcyclobutanol
2
valspodar
1
tremelimumab
1
tocilizumab
1
tanespimycin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Kidney Neoplasms
×
Interferons
×
Breast
×
Clear all
NCT00276536
2015-10-14
IFNa
The Cleveland Clinic
Phase 1
Completed
35 enrolled